Understanding the Market | 160 HEALTH surged over 10% in the closing session, reaching a new high since its listing, nearly doubling from its IPO price

160 HEALTH surged over 10% in the late trading session, reaching a new high of HKD 35, nearly doubling from the offering price of HKD 11.89. As of the time of publication, it rose 10.16% to HKD 34.92, with a trading volume of HKD 35.7908 million. It is reported that 160 HEALTH is an experienced wholesale distributor of pharmaceutical and health products in China and a leading provider of integrated digital healthcare services. The company offers a variety of pharmaceutical and health products, as well as comprehensive digital healthcare solutions. Additionally, the company provides digital healthcare solutions through its online healthcare service platform - the 160 HEALTH platform, empowering participants across the entire healthcare industry chain. As of March 31, 2025, the 160 HEALTH platform has connected over 44,600 healthcare institutions since its establishment, including more than 14,400 hospitals (including 3,430 tertiary hospitals) and over 30,200 grassroots medical and health institutions